Intervention Review

You have free access to this content

Intranasal ipratropium bromide for the common cold

  1. Zaina H AlBalawi1,*,
  2. Sahar S Othman2,
  3. Khalid AlFaleh3

Editorial Group: Cochrane Acute Respiratory Infections Group

Published Online: 19 JUN 2013

Assessed as up-to-date: 9 APR 2013

DOI: 10.1002/14651858.CD008231.pub3


How to Cite

AlBalawi ZH, Othman SS, AlFaleh K. Intranasal ipratropium bromide for the common cold. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD008231. DOI: 10.1002/14651858.CD008231.pub3.

Author Information

  1. 1

    University of Alberta, Department of Medicine, Edmonton, Alberta, Canada

  2. 2

    College of Medicine, King Abdulaziz University Hospital, Department of Family and Community Medicine, Jeddah, western, Saudi Arabia

  3. 3

    King Saud University, Department of Pediatrics (Division of Neonatology), Riyadh, Saudi Arabia

*Zaina H AlBalawi, Department of Medicine, University of Alberta, 11106 83 ave, Edmonton, Alberta, T6G0V1, Canada. Zaina.albalawi@ualberta.ca. Zaina7rb@yahoo.com.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 19 JUN 2013

SEARCH

[Figure 1]
Figure 1. 'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
[Figure 2]
Figure 2. 'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
[Figure 3]
Figure 3. Forest plot of comparison: 1 IB versus placebo, outcome: 1.1 Adverse effects.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Ipratropium bromide versus placebo, Outcome 1 Adverse effects.